Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 1 5Phase 1/2 2Phase NA 1Phase EARLY_PHASE1 1Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3Thoracic 2Dermatologic 2Other solid neoplasm 1Head & Neck 1Genitourinary 1

Conditions

Advanced Solid Tumor 1

Interventions

Pemetrexed 3sacituzumab govitecan 1ribociclib 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1encorafenib 1binimetinib 1Vincristine 1Sunitinib 1Sirolimus 1Raltegravir Potassium 1Paclitaxel 1One-Lung Ventilation 1Midazolam 1Leucovorin 1Itraconazole 1Irinotecan 1Immune Checkpoint Inhibitors 1Granulocyte-Macrophage Colony-Stimulating Factor 1Granulocyte Colony-Stimulating Factor 1Etoposide 1Drug Therapy 1Clinical Trials, Phase I as Topic 1Cetuximab 1Carboplatin 1Bevacizumab 1Anesthesia, General 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Immune Checkpoint Inhibitors × Other solid neoplasm × Clear all
NCT06408688 2024-12-27

ISCA-CHECK

University Hospital, Basel, Switzerland

Phase 4 Recruiting
100 enrolled
Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡